WB
OPRX icon

WesBanco Bank’s OptimizeRx OPRX Stock Holding History

WesBanco Bank’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$205K – 709
2025
Q3 		$205K Buy
+10,000
New +$159K 0.01% 662
2023
Q3 		– Sell
-16,531
Closed -$236K – 583
2023
Q2 		$236K Hold
16,531
– – 0.01% 526
2023
Q1 		$242K Hold
16,531
– – 0.01% 529
2022
Q4 		$278K Buy
+16,531
New +$286K 0.01% 502

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WesBanco Bank's OPRX Position: Q4 2025 in Review

WesBanco Bank sold out of OptimizeRx (OPRX) in Q4 2025, closing a stake of 10,000 shares — an estimated $205K sold.

WesBanco Bank first reported a position in OPRX in Q4 2022 and held it in 4 quarters. The position peaked at $278K in Q4 2022. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2025.

  • WesBanco Bank reported no remaining OptimizeRx position as of Q4 2025 after selling out during the quarter.
  • WesBanco Bank sold 10,000 OptimizeRx shares in Q4 2025, an estimated $205K.
  • WesBanco Bank first reported a position in OptimizeRx in Q4 2022 and held it in 4 quarters.
  • WesBanco Bank's OptimizeRx position peaked at $278K in Q4 2022.
  • 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2025.

Based on WesBanco Bank's 13F filing for Q4 2025, filed 3 Feb 2026.